Literature DB >> 6611247

Elevated ANA titers in patients with severely abnormal gastrointestinal motility.

E E Soffer, M P Strottmann, S Anuras.   

Abstract

We studied a group of six patients with clinical, radiological, and/or manometric features of severely abnormal gastrointestinal motility. Symptoms suggestive of esophageal, small bowel, or colonic involvement were present from 1 1/2 to 40 years. All patients had elevated antinuclear antibody (ANA) titers. None had clinical or radiographic features suggestive of progressive systemic sclerosis or other connective tissue diseases. Two patients had pathologic examinations of intestinal specimens, and these did not show changes suggestive of progressive systemic sclerosis. We conclude that patients with severe gastrointestinal motility disorders can have elevated ANA titers without features of progressive systemic sclerosis or other connective tissue diseases.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6611247     DOI: 10.1007/bf01312947

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  11 in total

1.  Scleroderma presenting as obstruction of the small bowel.

Authors:  W L TREACY; W L BUNTING; E E GAMBILL; C F CODE
Journal:  Proc Staff Meet Mayo Clin       Date:  1962-11-07

2.  The esophageal and small-bowel manifestations of progressive systemic sclerosis. A pathophysiologic explanation of the roentgenographic signs.

Authors:  W W Olmsted; J E Madewell
Journal:  Gastrointest Radiol       Date:  1976

3.  Progressive systemic sclerosis sine scleroderma.

Authors:  G P RODNAN; R H FENNELL
Journal:  JAMA       Date:  1962-05-26       Impact factor: 56.272

4.  Gastrointestinal manifestations of progressive systemic scleroderma based on a review of 364 cases.

Authors:  T J Poirier; G B Rankin
Journal:  Am J Gastroenterol       Date:  1972-07       Impact factor: 10.864

5.  Chronic intestinal pseudo-obstruction. A report of 27 cases and review of the literature.

Authors:  M D Schuffler; C A Rohrmann; R G Chaffee; D L Brand; J H Delaney; J H Young
Journal:  Medicine (Baltimore)       Date:  1981-05       Impact factor: 1.889

6.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

7.  Abnormal and sphincter response in chronically constipated children.

Authors:  V A Loening-Baucke; M K Younoszai
Journal:  J Pediatr       Date:  1982-02       Impact factor: 4.406

8.  The gastrointestinal manifestations of scleroderma: pathogenesis and management.

Authors:  S Cohen
Journal:  Gastroenterology       Date:  1980-07       Impact factor: 22.682

9.  Jejunal manometry patterns in health, partial intestinal obstruction, and pseudoobstruction.

Authors:  R W Summers; S Anuras; J Green
Journal:  Gastroenterology       Date:  1983-12       Impact factor: 22.682

10.  Progressive systemic sclerosis of the gastrointestinal tract and hereditary hollow visceral myopathy: two distinguishable disorders of intestinal smooth muscle.

Authors:  M D Schuffler; R G Beegle
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

View more
  1 in total

Review 1.  Pseudo-obstruction syndromes.

Authors:  V Stanghellini; R Corinaldesi; L Barbara
Journal:  Baillieres Clin Gastroenterol       Date:  1988-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.